Timothy E. Albertson, M.D., M.P.H., Ph.D.
Pulmonary and Critical Care
- Chair, Department of Internal Medicine
- Professor, Department of Internal Medicine
Philosophy of Care
I believe in caring for patients and their families with respect, dignity and compassion. I focus on communicating effectively with my patients, being sensitive to their overall needs and concerns as well as their immediate medical problem. I keep my patients informed, answer their questions frankly, and involve them and their families in any decision-making process.
At UC Davis Health, my patients can benefit from the highest level of care achievable because of our state-of-the-art resources, knowledge, skills and technology. As a long-time resident of the Sacramento area, I have established good relationships with many health-care professionals, and I enjoy working with our community physicians and other hospitals, sharing knowledge and expertise to provide quality patient
Dr. Albertson is a leading expert in Clinical Pharmacology and Toxicology, Aeromedicine, and Septic and Adult Respiratory Distress Syndrome.
Dr. Albertson's research and academic interests include: Sepsis, ARDS, Toxicology, Clinical research in IPF and Covid research.
Pulmonary, Critical Care, and Sleep Medicine
M.D., UC Davis School of Medicine, Sacramento CA 1977
M.S.S., U.S. Army War College, 2003
M.P.H., UC Berkeley School of Public Health, Berkeley CA 2003
M.S., Pharmacology and Toxicology, UC Davis, Davis CA 1976
Ph.D., Pharmacology and Toxicology, UC Davis, Davis CA 1980
B.A., Biology and Physiology, UC San Diego, San Diego CA 1973
Internship: Internal Medicine, University of Arizona, Tucson AZ 1977-1978
Internal Medicine, Critical Care Emergency Medicine, UC Davis, Davis CA 1980-1981
Internal Medicine, University of Arizona, Tucson AZ 1979-1980
Pulmonary and Critical Care Disease, UC Davis, Davis CA 1981-1983
Pharmacology, UC Davis, Davis CA 1978-1979
American Board of Emergency Medicine, 2017
American Board of Emergency Medicine, Medical Toxicology,
American Board of Internal Medicine,
American Board of Internal Medicine, Critical Care Medicine, 2017
American Board of Internal Medicine, Pulmonary Disease,
American College of Chest Physicians, Fellow
American College of Critical Care Medicine, Fellow
American College of Emergency Medicine, Fellow
American College of Medical Toxicology, Fellow
American College of Physicians, Fellow
American Thoracic Society
Association of Subspecialty Professors
Royal College of Physicians, London, Fellow
Society of Critical Care Medicine
Honors and Awards
Best Doctors in America List selected by a nationwide peer-review poll of physicians, 2017, 2018, 2019, 2020, 2021
Sacramento Magazine's Top Doctors List for Critical Care Medicine, Pulmonary Disease and Emergency Medicine, 2016, 2017, 2018, 2019, 2020, 2021
Distinguished Professor, 2019
United States Pharmacopoeia (USP) Award for an Outstanding Contribution to USP Standards: Healthcare Quality and Safety Expert Committee, 2016
Awarded the Order of California - California Military Department. The Order of California is the third highest award in the State�s pyramid of honor, and is the highest award for exceptionally meritorious service, 2016
Select Recent Publications
To see a full list of Dr. Albertson's publications, please click here.
Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Van Dromme I, Spiessens B, Vingerhoets J, Custers J, Scheper G, Robb ML, Treanor J, Ryser MF, Barouch DH, Swann E, Marovich MA, Neuzil KM, Corey L, Stoddard J, Hardt K, Ruiz-Guiñazú J, Le Gars M, Schuitemaker H, Van Hoof J, Struyf F, Douoguih M; ENSEMBLE Study Group. Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S. N Engl J Med. 2022 Mar 3;386(9):847-860. doi:10.1056/NEJMoa2117608. Epub 2022 Feb 9. PMID:35139271.
I-SPY COVID Consortium. Clinical trial design during and beyond the pandemic: the I-SPY COVID trial. Nat Med. 2022 Jan;28(1):9-11. doi:10.1038/s41591-021-01617-x. PMID:35058620.
Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Trial Investigators. REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19. N Engl J Med. 2021 Dec 2;385(23):e81. doi:10.1056/NEJMoa2108163.
Mir T, Uddin M, Qureshi WT, Abohashem S, Alqalyoobi S, Sheikh M, Soubani A, Saydain G, Albertson TE. ST-Elevation Myocardial Infarction Among Septic Shock and Coronary Interventions: A National Emergency Database Study. J Intensive Care Med. 2021 Nov 23:8850666211061731. doi:10.1177/08850666211061731. Epub ahead of print. PMID:34812084.
Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, C4591001 Clinical Trial Group. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. N Engl J Med. 2021 Nov 4;385(19): 1761-1773. doi:10.1056/NEJMoa2110345.
Friedman AN, Guirguis J, Kapoor R, Gupta S, Leaf DE, Timsina LR; STOP-COVID Investigators. Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US. Obesity (Silver Spring). 2021 Oct;29(10):1719-1730. doi:10.1002/oby.23245. Epub 2021 Aug 6. PMID:34109768.
Molinari L, Heskia F, Peerapornratana S, Ronco C, Guzzi L, Toback S, Birch R, Beyhaghi H, Kwan T, Kampf JP, Yealy DM, Kellum JA; Sapphire and Protocolized Care for Early Septic Shock (ProCESS) Investigators. Limiting Acute Kidney Injury Progression In Sepsis: Study Protocol and Trial Simulation. Crit Care Med. 2021 Oct 1;49(10):1706-1716. doi:10.1097/CCM.0000000000005061. PMID:33927121.
Lewis JC, Lim M, Lai L, Mendoza E, Albertson TE, Chenoweth JA. Evaluation of N-acetylcysteine dose for the treatment of massive acetaminophen ingestion. Clin Toxicol (Phila). 2021 Sep 28:1-7. doi:10.1080/15563650.2021.1984503. Epub ahead of print. PMID:34581655.